Tissue Expander Market Size, Share, and COVID-19 Impact Analysis By Application (Breast Reconstruction, Scalp Reconstruction, Maxillofacial Reconstruction, and Others), By Shape (Breast-shaped, Kidney-shaped, Rectangular, Cylindrical, and Others), By End-user (Hospitals & ASC, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

A tissue expander is a medical implant widely used in trauma-based reconstructive procedures. These devices, upon implantation, act like a balloon to stretch the tissue/skin covering the implant. Tissue expander has a wide range of applications in procedures associated with breast, scalp, and maxillofacial reconstruction.

The increase in the number of reconstruction surgeries worldwide is a significant factor driving the growth of the global tissue expander market. According to the data published by the American Society of Plastic Surgeons in 2020, breast reconstruction has been considered as one of the top 5 cosmetic surgical procedures since 2006. The increase in the use of tissue expanders in the reconstruction procedures for scalp reduction surgery and reconstruction of the face, neck, arms, and legs has led to a rise in demand for tissue expanders.

In addition, an increase in the number of severe road accidents and trauma cases coupled with a surge in the preference of individuals to undergo reconstructive surgeries in skin grafting procedures are factors contributing to the growth of the tissue expander market.

• For instance, according to data published by WHO, in 2023, around 20-50 million people are injured yearly due to road accidents. Road accidents most often require surgical treatment. Thus, the increase in road accidents leads to a rise in the demand for tissue expanders.

However, the lack of product availability in several emerging economies and prolonged tissue expansion procedures are expected to hamper the market's growth to a certain extent.

Impact of COVID-19 on the Tissue Expander Market

The tissue expander market witnessed a negative impact in 2020 during the COVID-19 pandemic due to a decline in the number of reconstructive and aesthetic procedures. Implementation of the lockdown due to the COVID-19 outbreak resulted in declined patient visits to hospitals, cosmetology clinics, and ambulatory surgical centers.

• For instance, according to data published by the European Journal of Plastic Surgery, in June 2021, the total number of surgeries decreased by 23.5% after the COVID-19 outbreak.

However, the relaxation of the rules imposed by the government, the resumption of hospital admissions, and surgical procedures in late 2020 and 2021 have brought the tissue expander market to the pre-pandemic year.

Key Insights

The report will cover the following key insights:

• Prevalence of Breast Cancer- by Key Countries/Regions, 2021/2022.
• New Product Launches.
• Technological Advancements in the Tissue Expander Technology.
• Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.).
• Impact of COVID-19 on the Market.

Analysis by Application

Based on application, the breast reconstruction segment accounted for a significant proportion of the global tissue expander market in 2022. The rise in the number of breast reconstructive surgeries is the major factor contributing to the growth of the breast reconstruction segment in 2022 and is projected to grow at a significant CAGR over the forecast period.

• For instance, according to data published by the American Society of Plastic Surgeons, in 2020, around 365,000 breast reconstruction surgeries were performed in 2021 in the U.S. increased by 44% compared to 2020. 

The scalp reconstruction segment is projected to grow at a significant CAGR over the forecast period owing to the rise in the number of scar removal procedures. In addition, the high prevalence of scarring alopecia and the increasing number of trauma & burn cases is projected to drive the growth of this segment over the forecast period.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America dominated the tissue expander market in 2022 and is projected to maintain its position over the forecast period. Factors such as growing healthcare expenditure, well-established healthcare infrastructure, and increased adoption of cosmetic surgeries are influencing the growth of the tissue expander market in North America. Moreover, Europe accounted for a significant market share in 2022 owing to the rise in cosmetic surgeries in European countries like the U.K.

The market for tissue expanders in Asia Pacific is expected to grow at a substantial market share over the forecast period. The growth is mainly attributed to the increase in trauma cases and severe road accidents in India. Furthermore, growth in the number of key players who manufacture tissue expanders and an increase in product approvals are projected to create lucrative growth opportunities for the market in the region.

• For instance, in January 2023, Motiva Implants and the Motiva Flora tissue expander products manufactured by Establishment Labs Holdings Inc. were approved by Japan's Pharmaceuticals and Medical Devices Agency (PMDA). They are reimbursable products for post-mastectomy reconstruction under the Japanese National Health System.

Key Players Covered

The report will include the profiles of key players such as Mentor Worldwide LLC, Sientra, Inc., PMT Corporation, Polytech Health and Aesthetics, Sebbin, Guangzhou Wanhe Plastic Materials Co., Ltd., Yuyao Jiusheng Medical Treatment Co., Ltd., Allergan, Koken Co., Ltd., GC Aesthetics, and others.

Segmentation

Key Industry Developments

• July 2022: GC Aesthetics, a manufacturer of aesthetic and reconstructive solutions, announced a strategic partnership with UMECO GROUP, a Korean medical device distributor focused on beauty, aesthetic, and medical markets.
• October 2022: GC Aesthetics announced the CE approval of the new micro-textured anatomical breast implant LUNA xt. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).